BOLIGNANO, DAVIDE
 Distribuzione geografica
Continente #
NA - Nord America 1.865
EU - Europa 1.488
AS - Asia 306
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 3.661
Nazione #
US - Stati Uniti d'America 1.861
SE - Svezia 532
IE - Irlanda 489
CN - Cina 242
UA - Ucraina 118
DE - Germania 116
IT - Italia 70
FI - Finlandia 68
GB - Regno Unito 51
SG - Singapore 37
IN - India 24
FR - Francia 18
CZ - Repubblica Ceca 11
BE - Belgio 10
CA - Canada 4
RU - Federazione Russa 3
IR - Iran 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CH - Svizzera 1
EC - Ecuador 1
IQ - Iraq 1
RO - Romania 1
Totale 3.661
Città #
Chandler 499
Dublin 489
Jacksonville 282
Nyköping 251
Beijing 118
Ashburn 94
Dearborn 90
Princeton 73
Cambridge 69
Medford 64
Des Moines 56
Ann Arbor 50
Boardman 50
New York 35
Bremen 25
Singapore 23
Lancaster 22
San Mateo 20
Woodbridge 19
Jinan 18
Wilmington 16
Pune 13
Nanjing 12
Seattle 12
Brussels 10
Shenyang 10
Hebei 9
Ningbo 9
Augusta 8
Brno 8
Houston 8
Falls Church 7
Haikou 7
Hyderabad 7
Nanchang 7
Tappahannock 7
Leawood 6
Jiaxing 5
Los Angeles 5
Norwalk 5
Tianjin 5
Washington 5
Zhengzhou 5
Hangzhou 4
Clearwater 3
Foggia 3
Guangzhou 3
Lanzhou 3
Lentini 3
Licata 3
Munich 3
Olomouc 3
Rome 3
Taiyuan 3
Taizhou 3
Bologna 2
Caltagirone 2
Capurso 2
Catania 2
Changsha 2
Fuzhou 2
Hefei 2
Helsinki 2
Messina 2
Mira 2
Montréal 2
Naples 2
Palermo 2
Porretta Terme 2
Toronto 2
Trento 2
Acquaviva Picena 1
Basel 1
Bergamo 1
Borgomasino 1
Brasov 1
Büdelsdorf 1
Cagliari 1
Croydon 1
Cuenca 1
Cupertino 1
Eschweiler 1
Fiumefreddo Di Sicilia 1
Florence 1
Fushan 1
Jeffries 1
Kunming 1
Milan 1
Mumbai 1
Napoli 1
Puxian 1
Redmond 1
Redwood City 1
Saint Paul 1
Siracusa 1
Xian 1
Yinchuan 1
Totale 2.628
Nome #
Both IL-1β and TNF-α Regulate NGALExpression in Polymorphonuclear Granulocytes ofChronic Hemodialysis Patients 83
Neutrophilgelatinase-associatedlipocalin(NGAL); un biomarker oltre i confini della nefrologia 78
Dialysis and the Elderly: An Underestimated Problem. 76
Urinary neutrophil gelatinase-associated lipocalin (uNGAL) levels in patients with Crohn’s disease undergoing treatment with infliximab. 72
The erythropoietin and regenerative medicine: a lesson from fish 71
Caffeine and the kidney: What evidence right now? 66
Effect of immunoglobulin treatment on endothelial progenitor cells in systemic lupus erythematosus 66
Alterations of lipid metabolism in chronic nephropathies: mechanisms, diagnosis and treatment. 66
Cold pressor test stimulates the mobilization of endothelial progenitor cells in hypertensive and uremic patients 65
A new therapy for kidney injury: regeneration. 63
Neurobiological model and quality of life in discovering personality of the uremic patient. 62
Neutrophil gelatinase-associated lipocalin serum evaluation through normal pregnancy and in pregnancies complicated by preeclampsia. 62
Aquaretic inhibits renal cancer proliferation: Role of vasopressin receptor-2 (V2-R). 62
Neutrophil gelatinase-associated lipocalin (NGAL): a new piece of the anemia puzzle? 59
Malnutrition in the elderly patient on dialysis. 59
A brief "update" on renal effects of caffeine 58
Acute cardiovascular complications of hemodialysis. 58
Down with the erythropoietin. Long live the erythropoietin! 58
Aquaporin-2 (AQP2) urinary excretion and assumption of water with different mineral content in healthy subjects 58
Circulating endothelial progenitor cell mobilization in centenarians: a powerful source for extended renal life. 57
Genomic damage in endothelial progenitor cells from uremic patients in hemodialysis 56
Renal complications in oncohematologic patients. 56
Arrhythmias and hemodialysis: role of potassium and new diagnostic tools. 56
Therapy with vasopressin receptor antagonists: the aquaretics 56
Perioperative iloprost and endothelial progenitor cells in uremic patients with severe limb ischemia undergoing peripheral revascularization. 55
Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: a new protein enters the scene. 55
From the oxygen to the organ protection: erythropoietin as protagonist in internal medicine 55
Aquaretic agents: What's beyond the treatment of hyponatremia? 54
Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease 54
Circulating progenitor cells after cold pressor test in hypertensive and uremic patients 54
Neutrophil gelatinase-associated lipocalin (NGAL) reflects iron status in haemodialysis patients 54
Effects of haemodialysis on circulating endothelial progenitor cell count 54
Aquaretic-induced apoptosis: a cure or a curse? 53
[Erythropoietin: pleiotropic actions]. 53
Experimental therapies in renal replacement: The effect of two different potassium acetate-free biofiltration protocols on striated muscle fibers 53
Xanthine oxidase inhibitors for improving renal function in chronic kidney disease patients: An updated systematic review and meta-analysis 53
Pathological and prognostic value of urinary neutrophil gelatinase-associated lipocalin in macroproteinuric patients with worsening renal function 52
Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage 52
Antioxidant agents for delaying diabetic kidney disease progression: A systematic review and meta-analysis 52
Neutrophil Gelatinase-Associated Lipocalin (NGAL) and progression of chronic kidney disease. 51
Erythropoietin and its lost receptor [8] 50
Levels of neutrophil gelatinase-associated lipocalin in 2 patients with crush syndrome after a mudslide. 49
Pregnancy in uremic patients: An eventful journey 48
Erythropoietin and its lost receptor. 47
Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients. 46
Relaxin: New Pathophysiological Aspects and Pharmacological Perspectives for an Old Protein. 46
Neutrophil gelatinase-associated lipocalin in patients with autosomal-dominant polycystic kidney disease. 45
Endothelial progenitor cells: pathogenetic role and therapeutic perspectives 45
Pulmonary hypertension and erythropoietin. 45
Neutrophil gelatinase-associated lipocalin immunoexpression in renal tumors: correlation with histotype and histological grade. 45
A case-by-case protocol of membranous nephropathy treatment with endovenous infusion of high doses of human immunoglobulins 44
Parathyroid hormone and mobilization of circulating bone marrow-derived cells in uremic patients. 44
Il Cold Pressor Test stimola la mobilizzazione di cellule staminali ad indirizzo endoteliale nei soggetti ipertesi ed uremici 44
Erythropoietin and cancer: an old risk. 43
Obestatin: a new element for mineral metabolism and inflammation in patients on hemodialysis. 43
RAS inhibition modulates kynurenine levels in a CKD population with and without type 2 diabetes mellitus 43
Regenerative medicine: does Erythropoietin have a role? 43
Modifications in relaxin's serum levels during acetate-free biofiltration (AFB): only a new biomarker? 40
null 39
NGAL is a precocious marker of therapeutic response. 39
From kidney to cardiovascular diseases: NGAL as a biomarker beyond the confines of nephrology. 39
Genomic damage in endothelial progenitor cells from uremic patients. 36
Antiproteinuric effect of DPP-IV inhibitors in diabetic and non-diabetic kidney diseases 36
Exploring the effects of DPP-4 inhibitors on the kidney from the bench to clinical trials 35
Endothelial progenitor cells at the interface of chronic kidney disease: from biology to therapeutic advancement 35
Osteoprotegerin and carotid atherosclerosis in dialysis patients: An imaging (ECO-Doppler) and genic expression study 34
NGAL: a new missing link between inflammation and uremic anemia? 33
Parathyroid hormone variability parameters for identifying high turnover osteodystrophy disease in hemodialysis patients: An observational retrospective cohort study 31
null 30
Neutrophil gelatinase-associated lipocalin in the intensive care unit: time to look beyond a single, threshold-based measurement? 27
Neutrophil gelatinase-associated lipocalin levels in chronic haemodialysis patients. 27
Preeclampsia and cardiovascular risk: general characteristics, counseling and follow-up. 21
Renal Concerns in the Treatment of Chronic Hepatitis B with Tenofovir 18
null 16
Neutrophil gelatinase-associated lipocalin levels in patients with crohn disease undergoing treatment with infliximab. 14
Totale 3.697
Categoria #
all - tutte 14.901
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.901


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020509 56 23 2 23 8 89 78 54 10 86 76 4
2020/2021408 63 4 69 33 16 60 6 24 7 39 57 30
2021/2022544 2 73 5 19 32 4 26 17 3 120 76 167
2022/20231.563 134 169 75 144 124 152 9 94 609 7 31 15
2023/2024326 31 50 14 32 27 98 2 21 0 14 5 32
2024/202521 21 0 0 0 0 0 0 0 0 0 0 0
Totale 3.697